论文部分内容阅读
永久性人工心脏起搏在临床上的应用已有 40余年的历史 ,其最初唯一的适应证是高度房室阻滞或病窦综合征所致的症状性心动过缓。随着医学工程技术的进步和临床研究的深入 ,不断研制出各种新型生理性起搏器 ,其功能日趋完善 ,使永久性心脏起搏治疗的适应证不断被拓宽 ,目前临床上已试用于防治心房颤动、充血性心力衰竭、肥厚型梗阻性心肌病、神经心源性晕厥、长QT综合征等。
Permanent artificial cardiac pacing in the clinical application of more than 40 years of history, the first indication of its own is a high incidence of atrioventricular block or sick sinus syndrome symptomatic bradycardia. With the advancement of medical engineering technology and in-depth clinical research, various new-type physiological pacemakers have been continuously developed and their functions have been improved day by day. As a result, the indications of permanent cardiac pacing therapy have been continuously broadened. At present, they have been clinically tested in Prevention and treatment of atrial fibrillation, congestive heart failure, hypertrophic obstructive cardiomyopathy, neurocardic syncope, long QT syndrome.